Canada Markets closed

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6976-0.0118 (-1.66%)
At close: 4:00PM EDT
0.6900 -0.01 (-1.09%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.5300
52 Week Low 30.6540
50-Day Moving Average 30.7641
200-Day Moving Average 30.9941

Share Statistics

Avg Vol (3 month) 33.52M
Avg Vol (10 day) 32.37M
Shares Outstanding 5102.84M
Implied Shares Outstanding 6N/A
Float 8142.83M
% Held by Insiders 11.35%
% Held by Institutions 129.87%
Shares Short (Jul. 29, 2021) 428.24M
Short Ratio (Jul. 29, 2021) 47.04
Short % of Float (Jul. 29, 2021) 420.51%
Short % of Shares Outstanding (Jul. 29, 2021) 418.48%
Shares Short (prior month Jun. 29, 2021) 428.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan. 17, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jan. 17, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-4,340.43%

Management Effectiveness

Return on Assets (ttm)-75.84%
Return on Equity (ttm)-387.27%

Income Statement

Revenue (ttm)3.41M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)78k
EBITDA -147.27M
Net Income Avi to Common (ttm)-150.07M
Diluted EPS (ttm)-2.1190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.98M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)78.14M
Total Debt/Equity (mrq)871.75
Current Ratio (mrq)1.40
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-162.94M
Levered Free Cash Flow (ttm)-128.71M